Dechun Jiang

419 total citations
24 papers, 282 citations indexed

About

Dechun Jiang is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Pharmacology. According to data from OpenAlex, Dechun Jiang has authored 24 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pediatrics, Perinatology and Child Health, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Dechun Jiang's work include Epilepsy research and treatment (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Dechun Jiang is often cited by papers focused on Epilepsy research and treatment (3 papers), Pharmacological Effects and Toxicity Studies (3 papers) and Neurological Disease Mechanisms and Treatments (2 papers). Dechun Jiang collaborates with scholars based in China, United States and Austria. Dechun Jiang's co-authors include Yuqin Wang, Suying Yan, Li Wang, Lin Li, Markus Müller, Wei Lu, Qingxia Zhang, Dan Jia, Jonathan Penm and Rebekah Moles and has published in prestigious journals such as Journal of Ethnopharmacology, Behavioural Brain Research and Analytical and Bioanalytical Chemistry.

In The Last Decade

Dechun Jiang

22 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dechun Jiang China 11 97 76 43 39 29 24 282
Kun‐Pin Hsieh Taiwan 12 33 0.3× 63 0.8× 78 1.8× 13 0.3× 47 1.6× 22 430
Juan del Llano Spain 9 30 0.3× 66 0.9× 28 0.7× 24 0.6× 46 1.6× 15 471
Tatsuhiko Anzai Japan 12 25 0.3× 28 0.4× 25 0.6× 13 0.3× 82 2.8× 51 382
Xiaojia Yu China 12 27 0.3× 11 0.1× 67 1.6× 37 0.9× 32 1.1× 31 377
Bhupendra Singh India 10 62 0.6× 15 0.2× 50 1.2× 22 0.6× 64 2.2× 37 317
Joanne Nguyen United States 8 46 0.5× 9 0.1× 62 1.4× 27 0.7× 11 0.4× 19 245
Yasuaki Mino Japan 14 90 0.9× 49 0.6× 73 1.7× 7 0.2× 10 0.3× 33 459
Sireen Abdul Rahim Shilbayeh Saudi Arabia 10 49 0.5× 15 0.2× 31 0.7× 27 0.7× 6 0.2× 51 276
Pengmei Li China 11 20 0.2× 10 0.1× 40 0.9× 21 0.5× 15 0.5× 46 283
Francesca Futura Bernardi Italy 9 29 0.3× 23 0.3× 43 1.0× 6 0.2× 7 0.2× 29 246

Countries citing papers authored by Dechun Jiang

Since Specialization
Citations

This map shows the geographic impact of Dechun Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dechun Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dechun Jiang more than expected).

Fields of papers citing papers by Dechun Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dechun Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dechun Jiang. The network helps show where Dechun Jiang may publish in the future.

Co-authorship network of co-authors of Dechun Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Dechun Jiang. A scholar is included among the top collaborators of Dechun Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dechun Jiang. Dechun Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Chunjing, et al.. (2025). Jingning formula alleviates ADHD by restoring gut microbiota dysbiosis and tryptophan metabolic dysfunction. Journal of Pharmaceutical and Biomedical Analysis. 269. 117256–117256.
3.
Bao, Li, et al.. (2024). Targeted Metabolomics Analysis of Serum Amino Acids in T2DM Patients. Diabetes Metabolic Syndrome and Obesity. Volume 17. 203–212. 5 indexed citations
4.
Bao, Li, et al.. (2024). Phillyrin alleviates high glucose-induced oxidative stress and inflammation in HBZY-1 cells through inhibition of the PI3K/Akt signaling pathway. Journal of Pharmacy and Pharmacology. 76(7). 776–787. 3 indexed citations
5.
Li, Bao, Ying Zhang, Guoying Zhang, Dechun Jiang, & Dan Yan. (2023). Abnormal proliferation of gut mycobiota contributes to the aggravation of Type 2 diabetes. Communications Biology. 6(1). 226–226. 15 indexed citations
7.
Zhang, Lei, et al.. (2023). Magnetic resonance imaging detects cerebral gray and white matter injury correlated with cognitive impairments in diabetic db/db mice. Behavioural Brain Research. 451. 114510–114510. 3 indexed citations
8.
Cui, Jingjing, et al.. (2023). Antitumor mechanism of kangliu pill on gliomas in mice through PI3K-Akt signaling pathway. Journal of Ethnopharmacology. 307. 116252–116252. 2 indexed citations
9.
Yang, Chunjing, et al.. (2022). Plasma metabolite profiles identify pediatric medulloblastoma and other brain cancer. Analytical and Bioanalytical Chemistry. 415(3). 471–480. 4 indexed citations
10.
Li, Huibo, Siqian Zheng, Da Li, et al.. (2021). The Establishment and Practice of Pharmacy Care Service Based on Internet Social Media: Telemedicine in Response to the COVID-19 Pandemic. Frontiers in Pharmacology. 12. 707442–707442. 23 indexed citations
11.
Jiang, Dechun, et al.. (2020). <p>High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant <em>Acinetobacter baumannii</em> in Intensive Care Unit</p>. Infection and Drug Resistance. Volume 13. 1447–1454. 6 indexed citations
12.
Zhuang, Wei, Xiaolan Lin, Bin Chen, et al.. (2020). Medication with caution: Analysis of adverse reactions caused by a combination of Chinese medicine and warfarin sodium tablets. Journal of Ethnopharmacology. 254. 112586–112586. 9 indexed citations
13.
Wang, Ke, et al.. (2019). Development of a list of high-risk perioperative medications for the elderly: a Delphi method. Expert Opinion on Drug Safety. 18(9). 853–859. 13 indexed citations
15.
Jiang, Dechun, et al.. (2015). Toll-like receptor 4 promotes fibrosis in bleomycin-induced lung injury in mice. Genetics and Molecular Research. 14(4). 17391–17398. 26 indexed citations
16.
Jiang, Dechun, et al.. (2010). Allergic shock and death associated with protamine administration in a diabetic patient. Clinical Therapeutics. 32(10). 1729–1732. 34 indexed citations
17.
Jiang, Dechun, Qingxia Zhang, Wei Lu, et al.. (2009). Effects of CYP2C19 and CYP2C9 genotypes on pharmacokinetic variability of valproic acid in Chinese epileptic patients: nonlinear mixed-effect modeling. European Journal of Clinical Pharmacology. 65(12). 1187–1193. 48 indexed citations
18.
Jiang, Dechun, et al.. (2007). Population pharmacokinetics of valproate in Chinese children with epilepsy. Acta Pharmacologica Sinica. 28(10). 1677–1684. 25 indexed citations
19.
Jiang, Dechun & Li Wang. (2004). Population pharmacokinetic model of valproate and prediction of valproate serum concentrations in children with epilepsy.. PubMed. 25(12). 1576–83. 11 indexed citations
20.
Jiang, Dechun & Chin‐Yang Li. (1995). Immunohistochemical study of the spleen in chronic immune thrombocytopenic purpura. With special reference to hyperplastic follicles and foamy macrophages.. PubMed. 119(6). 533–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026